The FDA called for a clinical hold on the two phase 1 trials of UCART123, in acute myeloid leukaemia, and in blastic plasmacytoid dendritic cell neoplasm (BPDCN). Cellectis said it is working with ...

Privately-held Menarini is paying up to $677 million for Stemline and Elzonris (tagraxofusp-erzs), the biotech’s treatment for blastic plasmacytoid dendritic cell neoplasm (BPDCN), which was ...

Innate immune cells are white blood cells that mediate innate immunity and include basophils, dendritic cells ... that preferentially accumulate in the tumor microenvironment of male mice and ...

Signet cell cancer is a rare type of cancer that mostly starts in the glandular cells. It is also called signet ring cell cancer. Nearly 57 out of 100 (57%) of all signet cell cancers start in the ...

Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer TA61 27 May 2003 27 May 2003 Guidance on the use of drugs for early thrombolysis in the treatment of acute ...

The study, published in Nature Communications, shows that a specific subtype of immune cell—type I dendritic ...